Early-onset lichenoid graft-vs.-host disease: a unique variant of acute graft-vs.-host disease occurring in peripheral blood stem cell transplant recipients

被引:1
|
作者
Magro, Cynthia M. [1 ]
Kerns, Mary Jo [2 ]
Votava, Henry [3 ]
Vasil, Katherine E. [4 ]
Dyrsen, Molly E. [1 ]
Morrison, Carl D. [5 ]
机构
[1] Cornell Univ, Weill Med Coll, New York, NY 10065 USA
[2] Univ Cincinnati, Dept Dermatol Cincinnatti, Cincinnati, OH 45221 USA
[3] NYU, Med Ctr, Div Dermatopathol, New York, NY 10016 USA
[4] Riverside Methodist Hosp, Columbus, OH 43214 USA
[5] Roswell Pk Canc Inst, Buffalo, NY USA
关键词
BONE-MARROW-TRANSPLANTATION; TOXIC EPIDERMAL NECROLYSIS; INCLUSION-BODY CHANGE; PATHOPHYSIOLOGY; MANIFESTATIONS; DIFFERENTIATE; MANAGEMENT; SPECTRUM; LESIONS; INJURY;
D O I
10.1111/j.1600-0560.2009.01427.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: A complication of stem cell transplantation is chronic graft-vs.-host disease (GvHD), developing months to years after transplant; the two commonest manifestations are lichenoid GvHD and scleroderma. The purpose of this study was to characterize early-onset lichenoid GvHD. Methods: A retrospective study identified patients diagnosed with early-onset lichenoid GvHD. This diagnosis was correlated with type of transplant and concurrent or prior episodes of acute GvHD. Results: Patients in whom a sex mismatch was present between donor and recipient were included, representing a study population of 17. All received an allogeneic peripheral blood stem cell transplant (PBSCT). All patients had biopsy proven lichenoid GvHD within 60 days or less following transplantation. All had concurrent gastrointestinal symptoms which was biopsy proven GvHD in thirteen of the cases. FISH XY studies revealed that the infiltrating lymphocytes were of donor origin in 12 of the cases, mixed in three and of host origin in two cases. Conclusions: Early-onset lichenoid GvHD is exclusive to the PBSCT setting and appears to be mediated by donor lymphocytes, reflecting the higher numbers of donor T cells encountered in PBSCT. We consider this reaction pattern a distinctive subtype of acute GvHD.
引用
收藏
页码:549 / 558
页数:10
相关论文
共 50 条
  • [21] Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation
    Rezvani, Andrew R.
    Storb, Rainer F.
    JOURNAL OF AUTOIMMUNITY, 2008, 30 (03) : 172 - 179
  • [22] Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease
    Zitzer, Nina C.
    Garzon, Ramiro
    Ranganathan, Parvathi
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [23] Daclizumab therapy for children with corticosteroid-resistant acute graft-vs.-host disease
    Schechter, Tal
    Afzal, Samina
    Finkelstein, Yaron
    Koren, Gideon
    Doyle, John
    Dupuis, L. Lee
    PEDIATRIC TRANSPLANTATION, 2009, 13 (03) : 332 - 337
  • [24] Generalized eczematoid graft-vs.-host disease: presentation and natural history
    Martyn-Simmons, CL
    Osborne, G
    Mufti, G
    Devereux, S
    Salisbury, J
    Creamer, D
    Du Vivier, AWP
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 : 19 - 19
  • [25] The molecular basis of salivary gland involvement in graft-vs.-host disease
    Nagler, RM
    Nagler, A
    JOURNAL OF DENTAL RESEARCH, 2004, 83 (02) : 98 - 103
  • [26] Ruxolitinib in steroid refractory graft-vs.-host disease: a case report
    Enrico Maffini
    Luisa Giaccone
    Moreno Festuccia
    Lucia Brunello
    Ilaria Buondonno
    Dario Ferrero
    Mario Boccadoro
    Chiara Dellacasa
    Alessandro Busca
    Domenico Novero
    Benedetto Bruno
    Journal of Hematology & Oncology, 9
  • [27] Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide
    Lia, Giuseppe
    Di Vito, Clara
    Bruno, Stefania
    Tapparo, Marta
    Brunello, Lucia
    Santoro, Armando
    Mariotti, Jacopo
    Bramanti, Stefania
    Zaghi, Elisa
    Calvi, Michela
    Comba, Lorenzo
    Fasci, Martina
    Giaccone, Luisa
    Camussi, Giovanni
    Boyle, Eileen M.
    Castagna, Luca
    Evangelista, Andrea
    Mavilio, Domenico
    Bruno, Benedetto
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [28] Bortezomib attenuates acute graft-vs.-host disease through interfering with host immature dendritic cells
    Tao, Yi
    Zhang, Weiwei
    Fang, Yuan
    Yang, Dan
    Wang, Liping
    Zhou, Hong
    Wang, Jianmin
    EXPERIMENTAL HEMATOLOGY, 2011, 39 (06) : 710 - 720
  • [29] Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients
    Chan, Edie Y.
    Larson, Anne M.
    Gernsheimer, Terry B.
    Kowdley, Kris V.
    Carithers, Robert L., Jr.
    Reyes, Jorge D.
    Perkins, James D.
    LIVER TRANSPLANTATION, 2007, 13 (04) : 516 - 522
  • [30] Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver
    Arat, M
    Idilman, R
    Soydan, EA
    Soykan, I
    Erden, E
    Karayalçin, S
    Akan, H
    CLINICAL TRANSPLANTATION, 2005, 19 (06) : 798 - 803